Vitruvias Therapeutics, based in Auburn, Alabama, has received a recall notice from the FDA for its medication.

The entities involved

• Alabama →

  state of the United States of America

  • Kay Ivey appointed Bill Poole as Finance Director in Alabama, where he represented Tuscaloosa in the House and the Department of Finance serves the state.Mon 17:49
  • Both Colorado and Alabama have reported serious health exceptions in their respective states.Mon 16:17
• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Related events

• Cronus Pharma LLC, headquartered in East Brunswick, is launching products in the U.S. market and seeking FDA approval.Aug 26
• The FDA is overseeing a product recall for tuna from Buckhead Meat Company, which is based in New Jersey.Sep 22
• Fate Therapeutics, based in San Diego, is seeking support for an accelerated regulatory pathway from the FDA.Aug 14
• BioXcel Therapeutics received FDA approval for its drug and announced results from New Haven.Jun 7
• UroGen Pharma Ltd., headquartered in Princeton, is seeking FDA approval for its products for the U.S. market.Sep 4